Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China
· Delayed Price · Currency is CNY 14.68
+0.15 (1.03%)
Apr 29, 2026, 3:00 PM CST
SHA:688526 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 935.65 | 933.04 | 1,027 | 974.14 | 1,083 | Upgrade
|
| Other Revenue | 14.09 | 8.88 | 37.14 | 27.12 | 19.86 | Upgrade
|
| Revenue | 949.74 | 941.92 | 1,064 | 1,001 | 1,103 | Upgrade
|
| Revenue Growth (YoY) | 0.83% | -11.48% | 6.27% | -9.22% | 30.81% | Upgrade
|
| Cost of Revenue | 330.72 | 360.45 | 321.43 | 279.05 | 230.42 | Upgrade
|
| Gross Profit | 619.03 | 581.48 | 742.65 | 722.22 | 872.6 | Upgrade
|
| Selling, General & Admin | 160.28 | 169.4 | 213.2 | 219.26 | 201.91 | Upgrade
|
| Research & Development | 96.41 | 86.12 | 88.51 | 102.75 | 80 | Upgrade
|
| Other Operating Expenses | 1.28 | -0.93 | -0.82 | 6.29 | 5.92 | Upgrade
|
| Operating Expenses | 247.8 | 266.47 | 385.36 | 339.01 | 296.9 | Upgrade
|
| Operating Income | 371.23 | 315.01 | 357.29 | 383.21 | 575.71 | Upgrade
|
| Interest Expense | 1.77 | -4.77 | -8.16 | -5.45 | -1.81 | Upgrade
|
| Interest & Investment Income | 63.83 | 73.17 | 94.12 | 75.69 | 71.86 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.89 | 0 | 0.05 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.63 | -0.72 | -0.21 | -0.2 | -0.27 | Upgrade
|
| EBT Excluding Unusual Items | 435.31 | 382.69 | 443.1 | 453.25 | 645.48 | Upgrade
|
| Impairment of Goodwill | - | -3.31 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 33.27 | 30.99 | -10.19 | 1.44 | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.93 | - | - | - | Upgrade
|
| Asset Writedown | -1.28 | -0.86 | -1.72 | -0.14 | -1.57 | Upgrade
|
| Legal Settlements | - | - | - | - | 0.82 | Upgrade
|
| Other Unusual Items | 14.24 | 27.7 | 26.39 | 12.06 | 15.32 | Upgrade
|
| Pretax Income | 481.54 | 438.13 | 457.58 | 466.61 | 660.05 | Upgrade
|
| Income Tax Expense | 64.6 | 56.64 | 62 | 57.46 | 89.41 | Upgrade
|
| Earnings From Continuing Operations | 416.94 | 381.49 | 395.58 | 409.15 | 570.64 | Upgrade
|
| Minority Interest in Earnings | 1.78 | 0.86 | 0.35 | 0.37 | 0.11 | Upgrade
|
| Net Income | 418.72 | 382.35 | 395.93 | 409.52 | 570.74 | Upgrade
|
| Net Income to Common | 418.72 | 382.35 | 395.93 | 409.52 | 570.74 | Upgrade
|
| Net Income Growth | 9.51% | -3.43% | -3.32% | -28.25% | 27.45% | Upgrade
|
| Shares Outstanding (Basic) | 465 | 466 | 466 | 465 | 464 | Upgrade
|
| Shares Outstanding (Diluted) | 465 | 466 | 466 | 465 | 464 | Upgrade
|
| Shares Change (YoY) | -0.22% | 0.10% | 0.10% | 0.29% | 20.20% | Upgrade
|
| EPS (Basic) | 0.90 | 0.82 | 0.85 | 0.88 | 1.23 | Upgrade
|
| EPS (Diluted) | 0.90 | 0.82 | 0.85 | 0.88 | 1.23 | Upgrade
|
| EPS Growth | 9.76% | -3.53% | -3.41% | -28.46% | 6.03% | Upgrade
|
| Free Cash Flow | 344.66 | 285.74 | 433.53 | 320.86 | 156.82 | Upgrade
|
| Free Cash Flow Per Share | 0.74 | 0.61 | 0.93 | 0.69 | 0.34 | Upgrade
|
| Dividend Per Share | 0.640 | 0.430 | 0.430 | 0.190 | 0.190 | Upgrade
|
| Dividend Growth | 48.84% | - | 126.32% | - | -34.48% | Upgrade
|
| Gross Margin | 65.18% | 61.73% | 69.79% | 72.13% | 79.11% | Upgrade
|
| Operating Margin | 39.09% | 33.44% | 33.58% | 38.27% | 52.19% | Upgrade
|
| Profit Margin | 44.09% | 40.59% | 37.21% | 40.90% | 51.74% | Upgrade
|
| Free Cash Flow Margin | 36.29% | 30.34% | 40.74% | 32.05% | 14.22% | Upgrade
|
| EBITDA | 482.99 | 423.23 | 470.54 | 480.16 | 638.35 | Upgrade
|
| EBITDA Margin | 50.85% | 44.93% | 44.22% | 47.95% | 57.87% | Upgrade
|
| D&A For EBITDA | 111.76 | 108.22 | 113.24 | 96.95 | 62.64 | Upgrade
|
| EBIT | 371.23 | 315.01 | 357.29 | 383.21 | 575.71 | Upgrade
|
| EBIT Margin | 39.09% | 33.44% | 33.58% | 38.27% | 52.19% | Upgrade
|
| Effective Tax Rate | 13.41% | 12.93% | 13.55% | 12.31% | 13.55% | Upgrade
|
| Revenue as Reported | 949.74 | 941.92 | 1,064 | 1,001 | 1,103 | Upgrade
|
| Advertising Expenses | 25.46 | 25.7 | 34.1 | 2.87 | 2.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.